• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用血清的低角度X射线散射特征对肝硬化和肝细胞癌进行表征。

Characterization of cirrhosis and hepatocellular carcinoma using low-angle x-ray scattering signatures of serum.

作者信息

Elshemey Wael M, Desouky Omar S, Mohammed Mohammed S, Elsayed Anwar A, el-Houseini Motawa E

机构信息

Biophysics Department, Faculty of Science, Cairo University, Egypt.

出版信息

Phys Med Biol. 2003 Sep 7;48(17):N239-46. doi: 10.1088/0031-9155/48/17/401.

DOI:10.1088/0031-9155/48/17/401
PMID:14516110
Abstract

The diagnosis of hepatocellular carcinoma (HCC) usually occurs at late stages in the disease when there are few effective treatment options. The measurement of the concentration of tumour markers in the serum of patients is a complementary tool frequently used for the interpretation of diagnostic imaging results. It is also used as a prognostic tool for the detection of cancer. Unfortunately, the sensitivity of tumour markers is still low and many times it yields normal results for cirrhotic and HCC patients. In the current work, the detection possibility of the structural changes in serum proteins accompanying cirrhosis and HCC is investigated using a low-angle x-ray scattering (LAXS) technique. The results show that there are significant differences in the LAXS profiles of cirrhosis and HCC lyophilized serum samples compared to normal. The changes in shape, total counts and position of the first scattering peak at 4.8 degrees, which was previously reported to be sensitive to the structural changes in protein, showed the most characteristic deviations from normal serum. The present results are promising and would offer a potentially helpful complementary tool for monitoring cirrhosis and HCC.

摘要

肝细胞癌(HCC)的诊断通常在疾病晚期进行,此时有效的治疗选择很少。检测患者血清中肿瘤标志物的浓度是一种常用的辅助工具,用于解读诊断成像结果。它也被用作检测癌症的预后工具。不幸的是,肿瘤标志物的敏感性仍然较低,很多时候肝硬化和HCC患者的检测结果仍为正常。在当前的研究中,使用低角度X射线散射(LAXS)技术研究了肝硬化和HCC患者血清蛋白结构变化的检测可能性。结果表明,与正常血清相比,肝硬化和HCC冻干血清样本的LAXS图谱存在显著差异。先前报道对蛋白质结构变化敏感的4.8度处第一个散射峰的形状、总计数和位置变化显示出与正常血清最显著的偏差。目前的结果很有前景,将为监测肝硬化和HCC提供一种潜在有用的辅助工具。

相似文献

1
Characterization of cirrhosis and hepatocellular carcinoma using low-angle x-ray scattering signatures of serum.利用血清的低角度X射线散射特征对肝硬化和肝细胞癌进行表征。
Phys Med Biol. 2003 Sep 7;48(17):N239-46. doi: 10.1088/0031-9155/48/17/401.
2
Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.埃及患者中用于早期检测丙型肝炎病毒感染相关肝细胞癌的血清生物标志物
Asian Pac J Cancer Prev. 2015;16(3):1281-7. doi: 10.7314/apjcp.2015.16.3.1281.
3
Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.评估肝硬化患者的肝细胞癌:临床症状、影像学检查及甲胎蛋白的价值
Oncology. 2007;72 Suppl 1:117-23. doi: 10.1159/000111717. Epub 2007 Dec 13.
4
Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma.循环微小RNA-200家族作为肝细胞癌的诊断标志物
PLoS One. 2015 Oct 8;10(10):e0140066. doi: 10.1371/journal.pone.0140066. eCollection 2015.
5
Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.生长分化因子15血清水平与肝硬化和肝细胞癌的关联
PLoS One. 2015 May 21;10(5):e0127518. doi: 10.1371/journal.pone.0127518. eCollection 2015.
6
Serum level of soluble vascular cell adhesion molecule in patients with hepatocellular carcinoma and its association with severity of liver disease.血清可溶性血管细胞黏附分子水平与肝癌患者肝功能严重程度的关系。
Ann Hepatol. 2013 Mar-Apr;12(2):236-47.
7
Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.丙型肝炎病毒感染合并肝细胞癌的早期检测:一种数学模型。
World J Gastroenterol. 2016 Apr 28;22(16):4168-82. doi: 10.3748/wjg.v22.i16.4168.
8
Diagnosis of hepatocellular carcinoma in cirrhotic patients: a proof-of-concept study using serum micro-Raman spectroscopy.肝硬化患者肝细胞癌的诊断:基于血清微拉曼光谱的概念验证研究。
Analyst. 2013 Jul 21;138(14):4006-14. doi: 10.1039/c3an00245d.
9
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma.血浆孤啡肽/孤啡肽FQ在肝细胞癌诊断中的低效用。
World J Gastroenterol. 2006 Aug 7;12(29):4716-20. doi: 10.3748/wjg.v12.i29.4716.
10
Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.采用高敏电化学发光系统检测血清去γ-羧基凝血酶原水平的序贯波动模式,作为肝硬化患者肝细胞癌的早期预测标志物。
Int J Mol Med. 2002 Mar;9(3):245-50.

引用本文的文献

1
The influence of hydration on the architectural rearrangement of normal and neoplastic human breast tissues.水合作用对正常和肿瘤性人类乳腺组织结构重排的影响。
Heliyon. 2019 Feb 18;5(2):e01219. doi: 10.1016/j.heliyon.2019.e01219. eCollection 2019 Feb.
2
Curcumin: a unique antioxidant offers a multimechanistic approach for management of hepatocellular carcinoma in rat model.姜黄素:一种独特的抗氧化剂为大鼠模型中肝细胞癌的管理提供了多机制方法。
Tumour Biol. 2015 Mar;36(3):1667-78. doi: 10.1007/s13277-014-2767-2. Epub 2014 Nov 5.
3
Diagnostic value of alpha-L-fucosidase for hepatocellular carcinoma: a meta-analysis.
α-L-岩藻糖苷酶对肝细胞癌的诊断价值:一项Meta分析
Tumour Biol. 2014 May;35(5):3953-60. doi: 10.1007/s13277-013-1563-8. Epub 2014 Jan 7.
4
Using X-ray in-line phase-contrast imaging for the investigation of nude mouse hepatic tumors.应用 X 射线相衬成像技术研究裸鼠肝肿瘤。
PLoS One. 2012;7(6):e39936. doi: 10.1371/journal.pone.0039936. Epub 2012 Jun 28.